30.8 C
Kuala Lumpur
Friday, August 19, 2022
HomeSocial NewsLatest update on COVID-19 Self Test Section Through MySejahtera

Latest update on COVID-19 Self Test Section Through MySejahtera

MySejahtera has rolled out a new update that has added a new section into the app called COVID-19 Self-Test. The new section features three self test kits have been approved by MoH.

In many ways, this is a timely update as the Ministry of Health has recently provided conditional approval for several self-test kits which are now already available at pharmacies.

The section features three self-test kits including Salixium, Gmate, and JusChek. While the new section surely made things more convenient when you have to upload the self-test results, it actually does not involve a deep integration with MySejahatera’s mobile app.

In general, the main function of the new section is to provide users quick access to the self-test section of MySejahtera’s helpdesk which is actually a web app that runs outside of the mobile app. For those who used Salixium, there is also an extra option that would bring them to the test kit’s own web app.

Besides, the COVID-19 Self-Test section also includes a link to an online pharmacy called Pharma2u. The website didn’t specifically mention the name of the company that operates Pharma2u, although there is a remark on the site that says it is a Malaysian-based company.

At the moment, Pharma2u does not offer any other products aside from the three self-test kits that we mentioned earlier. Additionally, the site also highlights the teleconsulting service by Dr Ezy that customers can sign up if they are not sure that they can perform the test themselves and want a medical consultant to monitor the test remotely.

Delivered through update v1.0.40, it is now readily available for Android and iOS users. For Huawei users, it seems that the MySejahtera team has yet to roll out the new update to the AppGallery since the version listed on the app marketplace is still v1.0.39 at the time this article was published.

Leave a reply

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments